lioton 1000 8,5 mg/g Żel
a. menarini industrie farmaceutiche riunite s.r.l. - heparinum natricum - Żel - 8,5 mg/g
nebilet 5 mg tabletki
berlin-chemie ag (menarini group) - nebivololi hydrochloridum - tabletki - 5 mg
siofor 500 500 mg tabletki powlekane
berlin-chemie ag (menarini group) - metformini hydrochloridum - tabletki powlekane - 500 mg
espumisan 100 mg/ml 100 mg/ml krople doustne, emulsja
berlin-chemie ag (menarini group) - simeticonum - krople doustne, emulsja - 100 mg/ml
mig dla dzieci 100 mg/5 ml zawiesina doustna
berlin-chemie ag (menarini group) - ibuprofenum - zawiesina doustna - 100 mg/5 ml
siofor 850 850 mg tabletki powlekane
berlin-chemie ag (menarini group) - metformini hydrochloridum - tabletki powlekane - 850 mg
elzonris
stemline therapeutics b.v. - tagraxofusp - lymphoma - Środki przeciwnowotworowe - elzonris is indicated as monotherapy for the first-line treatment of adult patients with blastic plasmacytoid dendritic cell neoplasm (bpdcn).
nexpovio
stemline therapeutics b.v. - selinexor - szpiczak mnogi - Środki przeciwnowotworowe - nexpovio is indicatedin combination with bortezomib and dexamethasone for the treatment of adult patients with multiple myeloma who have received at least one prior therapy. in combination with dexamethasone for the treatment of multiple myeloma in adult patients who have received at least four prior therapies and whose disease is refractory to at least two proteasome inhibitors, two immunomodulatory agents and an anti-cd38 monoclonal antibody, and who have demonstrated disease progression on the last therapy.
orserdu
stemline therapeutics b.v. - elacestrant - nowotwory piersi - terapia endokrynologiczna - orserdu monotherapy is indicated for the treatment of postmenopausal women, and men, with estrogen receptor (er) positive, her2-negative, locally advanced or metastatic breast cancer with an activating esr1 mutation who have disease progression following at least one line of endocrine therapy including a cdk 4/6 inhibitor.
anoro ellipta (previously anoro)
glaxosmithkline (ireland) limited - bromek umeclidinium, vilanterol trifenatate - choroba płuc, przewlekła obturacyjna - preparaty do obturacyjne choroby dróg oddechowych, - anoro ellipta jest wskazany jako leczenie podtrzymujące bronchodilator, aby złagodzić objawy u dorosłych pacjentów z przewlekłą obturacyjną chorobą płuc (pochp).